Maze Therapeutics MAZE
NASDAQ MAZE
$32.44 +2.74 (+9.24%)
As of: Oct 20, 2026 · 3:59 PM EDT

Maze Therapeutics (MAZE) Payables (2024 - 2026)

Updated

Maze Therapeutics (MAZE) recorded Payables of $2.21 million in Q2 2026, down 39.7% from $3.67 million a year earlier and down 44.9% from the prior quarter.

Analysis

Maze Therapeutics (MAZE) Payables (2024 - 2026) Analysis & Trends

At the end of FY2025, Maze Therapeutics reported Payables of $1.79 million, down 7.5% from FY2024.

  • Across earlier years, Payables came in at $1.94 million in FY2024.
  • Quarterly Payables has ranged from $1.79 million in Q4 2025 to $4.01 million in Q1 2026 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $4.01 million (Q1 2026), $1.79 million (Q4 2025) and $2.92 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 6.11 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 20.92 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 33.30 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 5.96 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 4.26 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 22.89 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 2.87 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 674.00 Mn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 7.03 Bn
10 Maze Therapeutics 1.91 Bn 417.43 Mn - 2.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.21 Mn
Mar 31, 2026 4.01 Mn
Dec 31, 2025 1.79 Mn
Sep 30, 2025 2.92 Mn
Jun 30, 2025 3.67 Mn
Mar 31, 2025 2.40 Mn
Dec 31, 2024 1.94 Mn
API Access

Maze Therapeutics Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=MAZE&period=max&api_key=YOUR_API_KEY